Interaksi Probenesid

Probenesid memiliki 111 interaksi terdokumentasi dalam label FDA dan lembar fakta yang kami indeks: 27 mayor, 64 moderat, 18 minor, dan 2 dengan label yang melaporkan tidak ada interaksi bermakna. Setiap entri di bawah ini mengutip kalimat yang mendasarinya. Halaman obat ini adalah titik awal, bukan putusan untuk situasi Anda.

Interaksi dari label

Interaksi mayor (27)

  • Amoksisilin dan klavulanatantibiotik penisilinMayor

    Co-administration with probenecid is not recommended. (label Amoksisilin dan klavulanat, Interaksi obat)

  • AspirinOAINSMayor

    In patients on probenecid the use of salicylates in either small or large doses is contraindicated because it antagonizes the uricosuric action of probenecid. (label Probenesid, Peringatan)

  • Aspirin dan dipiridamolantiplateletMayor

    In patients on probenecid the use of salicylates in either small or large doses is contraindicated because it antagonizes the uricosuric action of probenecid. (label Probenesid, Peringatan)

  • BalsalazidsalisilatMayor

    In patients on probenecid the use of salicylates in either small or large doses is contraindicated because it antagonizes the uricosuric action of probenecid. (label Probenesid, Peringatan)

  • Bismut subsalisilatsalisilatMayor

    In patients on probenecid the use of salicylates in either small or large doses is contraindicated because it antagonizes the uricosuric action of probenecid. (label Probenesid, Peringatan)

  • Bumetaniddiuretik loopMayor

    Thus, probenecid should not be administered concurrently with bumetanide. (label Bumetanid, Interaksi obat)

  • In patients on probenecid the use of salicylates in either small or large doses is contraindicated because it antagonizes the uricosuric action of probenecid. (label Probenesid, Peringatan)

  • In patients on probenecid the use of salicylates in either small or large doses is contraindicated because it antagonizes the uricosuric action of probenecid. (label Probenesid, Peringatan)

  • Deferipronsuplemen zat besiMayor

    Effect of Other Drugs on FERRIPROX UDP-Glucuronosyltransferases (UGT) Avoid use of UGT1A6 inhibitors (e.g., diclofenac, probenecid, or silymarin (milk thistle)) with FERRIPROX [ see Dosage and Administration ( 2.2 ) , Adverse Reactions ( 6.1 ), Clinical Pharmacology ( 12.3 ) ] . (label Deferipron, Interaksi obat)

  • DiflunisalOAINSMayor

    In patients on probenecid the use of salicylates in either small or large doses is contraindicated because it antagonizes the uricosuric action of probenecid. (label Probenesid, Peringatan)

  • ErtapenemantibiotikMayor

    Co-administration with probenecid inhibits the renal excretion of ertapenem and is therefore not recommended. (label Ertapenem, Interaksi obat)

  • Therefore, it is not recommended that probenecid be given concomitantly with PRIMAXIN. (label Imipenem dan silastatin, Interaksi obat)

  • KetoprofenOAINSMayor

    Therefore, the combination of ketoprofen and probenecid is not recommended. (label Ketoprofen, Peringatan dan perhatian)

  • KetorolakOAINSMayor

    The concomitant use of ketorolac tromethamine and probenecid is contraindicated. (label Ketorolak, Kontraindikasi)

  • In patients on probenecid the use of salicylates in either small or large doses is contraindicated because it antagonizes the uricosuric action of probenecid. (label Probenesid, Peringatan)

  • MeropenemantibiotikMayor

    Co-administration of Meropenem for injection with probenecid inhibits renal excretion of meropenem and is therefore not recommended ( 7.1 ) (label Meropenem, Interaksi obat)

  • MesalazinsalisilatMayor

    In patients on probenecid the use of salicylates in either small or large doses is contraindicated because it antagonizes the uricosuric action of probenecid. (label Probenesid, Peringatan)

  • In patients on probenecid the use of salicylates in either small or large doses is contraindicated because it antagonizes the uricosuric action of probenecid. (label Probenesid, Peringatan)

  • Piperasilin dan tazobaktamantibiotik penisilinMayor

    Probenecid prolongs the half-lives of piperacillin and tazobactam and should not be co-administered with Piperacillin and Tazobactam for Injection and Sodium Chloride Injection unless the benefit outweighs the risk. (label Piperasilin dan tazobaktam, Interaksi obat)

  • PralatreksatantimetabolitMayor

    Avoid coadministration with probenecid or nonsteroidal anti-inflammatory drugs. (label Pralatreksat, Interaksi obat)

  • SalsalatOAINSMayor

    In patients on probenecid the use of salicylates in either small or large doses is contraindicated because it antagonizes the uricosuric action of probenecid. (label Probenesid, Peringatan)

  • SefaleksinsefalosporinMayor

    Co-administration of probenecid with cephalexin for oral suspension is not recommended. (label Sefaleksin, Interaksi obat)

  • SefazolinsefalosporinMayor

    Co-administration of probenecid with Cefazolin for Injection is not recommended. (label Sefazolin, Interaksi obat)

  • SefotaksimsefalosporinMayor

    Administration of cefotaxime in excess of 6 grams/day should be avoided in patients receiving probenecid (see CLINICAL PHARMACOLOGY, Drug Interactions ). (label Sefotaksim, Interaksi obat)

  • SefuroksimsefalosporinMayor

    Coadministration with probenecid increases systemic exposure to cefuroxime axetil and is therefore not recommended. (label Sefuroksim, Interaksi obat)

  • SidofovirantivirusMayor

    TO REDUCE POSSIBLE NEPHROTOXICITY, INTRAVENOUS PREHYDRATION WITH NORMAL SALINE AND ADMINISTRATION OF PROBENECID MUST BE USED WITH EACH CIDOFOVIR INFUSION. (label Sidofovir, Peringatan kotak hitam)

  • SulfasalazinsulfonamidaMayor

    In patients on probenecid the use of salicylates in either small or large doses is contraindicated because it antagonizes the uricosuric action of probenecid. (label Probenesid, Peringatan)

Interaksi moderat (64)

  • Amoksisilinantibiotik penisilinModerat

    Drug Interactions When probenecid is used to elevate plasma concentrations of penicillin or other beta-lactams, or when such drugs are given to patients taking probenecid therapeutically, high plasma concentrations of the other drug may increase the incidence of adverse reactions associated with that drug. (label Probenesid, Interaksi obat)

  • Ampisilinantibiotik penisilinModerat

    Drug Interactions When probenecid is used to elevate plasma concentrations of penicillin or other beta-lactams, or when such drugs are given to patients taking probenecid therapeutically, high plasma concentrations of the other drug may increase the incidence of adverse reactions associated with that drug. (label Probenesid, Interaksi obat)

  • Ampisilin dan sulbaktamantibiotik penisilinModerat

    Drug Interactions When probenecid is used to elevate plasma concentrations of penicillin or other beta-lactams, or when such drugs are given to patients taking probenecid therapeutically, high plasma concentrations of the other drug may increase the incidence of adverse reactions associated with that drug. (label Probenesid, Interaksi obat)

  • Asetazolamidpenghambat karbonat anhidraseModerat

    Probenecid produces an insignificant increase in free sulfonamide plasma concentrations but a significant increase in total sulfonamide plasma levels. (label Probenesid, Interaksi obat)

  • AsiklovirantivirusModerat

    Drug Interactions Coadministration of probenecid with intravenous acyclovir has been shown to increase the mean acyclovir half-life and the area under the concentration-time curve. (label Asiklovir, Interaksi obat)

  • Barisitinibpenghambat JAKModerat

    In patients taking strong Organic Anion Transporter 3 (OAT3) inhibitors (e.g., probenecid) the recommended dosage should be reduced. (label Barisitinib, Interaksi obat)

  • Benzilpenisilin (penisilin G)antibiotik penisilinModerat

    Drug Interactions When probenecid is used to elevate plasma concentrations of penicillin or other beta-lactams, or when such drugs are given to patients taking probenecid therapeutically, high plasma concentrations of the other drug may increase the incidence of adverse reactions associated with that drug. (label Probenesid, Interaksi obat)

  • Brinzolamidpenghambat karbonat anhidraseModerat

    Probenecid produces an insignificant increase in free sulfonamide plasma concentrations but a significant increase in total sulfonamide plasma levels. (label Probenesid, Interaksi obat)

  • Bromokriptinagonis dopaminModerat

    Therefore, CYCLOSET may increase the unbound fraction of other concomitantly used highly protein-bound therapies (e.g., salicylates, sulfonamides, chloramphenicol and probenecid), which may alter their effectiveness and risk for side effects. (label Bromokriptin, Interaksi obat)

  • In patients on probenecid who require a mild analgesic agent the use of acetaminophen rather than small doses of salicylates would be preferred. (label Probenesid, Peringatan)

  • In patients on probenecid who require a mild analgesic agent the use of acetaminophen rather than small doses of salicylates would be preferred. (label Probenesid, Peringatan)

  • In patients on probenecid who require a mild analgesic agent the use of acetaminophen rather than small doses of salicylates would be preferred. (label Probenesid, Peringatan)

  • Dikloksasilinantibiotik penisilinModerat

    Drug Interactions When probenecid is used to elevate plasma concentrations of penicillin or other beta-lactams, or when such drugs are given to patients taking probenecid therapeutically, high plasma concentrations of the other drug may increase the incidence of adverse reactions associated with that drug. (label Probenesid, Interaksi obat)

  • Diklorfenamidpenghambat karbonat anhidraseModerat

    Probenecid produces an insignificant increase in free sulfonamide plasma concentrations but a significant increase in total sulfonamide plasma levels. (label Probenesid, Interaksi obat)

  • Dorzolamidpenghambat karbonat anhidraseModerat

    Probenecid produces an insignificant increase in free sulfonamide plasma concentrations but a significant increase in total sulfonamide plasma levels. (label Probenesid, Interaksi obat)

  • Dorzolamid dan timololpenghambat karbonat anhidraseModerat

    Probenecid produces an insignificant increase in free sulfonamide plasma concentrations but a significant increase in total sulfonamide plasma levels. (label Probenesid, Interaksi obat)

  • FamsiklovirantivirusModerat

    Probenecid: May increase penciclovir levels. (label Famsiklovir, Interaksi obat)

  • Fenoksimetilpenisilin (penisilin V)antibiotik penisilinModerat

    Drug Interactions When probenecid is used to elevate plasma concentrations of penicillin or other beta-lactams, or when such drugs are given to patients taking probenecid therapeutically, high plasma concentrations of the other drug may increase the incidence of adverse reactions associated with that drug. (label Probenesid, Interaksi obat)

  • GansiklovirantivirusModerat

    Probenecid ↑Ganciclovir Ganciclovir for Injection dose may need to be reduced. (label Gansiklovir, Interaksi obat)

  • GlibenklamidsulfonilureaModerat

    Probenecid may prolong or enhance the action of oral sulfonylureas and thereby increase the risk of hypoglycemia. (label Probenesid, Interaksi obat)

  • Glibenklamid dan metforminsulfonilureaModerat

    Probenecid may prolong or enhance the action of oral sulfonylureas and thereby increase the risk of hypoglycemia. (label Probenesid, Interaksi obat)

  • GlimepiridsulfonilureaModerat

    Probenecid may prolong or enhance the action of oral sulfonylureas and thereby increase the risk of hypoglycemia. (label Probenesid, Interaksi obat)

  • GlipizidsulfonilureaModerat

    Probenecid may prolong or enhance the action of oral sulfonylureas and thereby increase the risk of hypoglycemia. (label Probenesid, Interaksi obat)

  • Glipizid dan metforminsulfonilureaModerat

    Probenecid may prolong or enhance the action of oral sulfonylureas and thereby increase the risk of hypoglycemia. (label Probenesid, Interaksi obat)

  • In patients on probenecid who require a mild analgesic agent the use of acetaminophen rather than small doses of salicylates would be preferred. (label Probenesid, Peringatan)

  • IndometasinOAINSModerat

    Probenecid Clinical Impact: When indomethacin is given to patients receiving probenecid, the plasma levels of indomethacin are likely to be increased. (label Indometasin, Interaksi obat)

  • Monitor patients for increased toxicity when MRP2 inhibitors (e.g., abacavir, adefovir, cidofovir, furosemide, lamivudine, nevirapine, ritonavir, probenecid, saquinavir, and tenofovir) are co-administered with COMETRIQ [see Clinical Pharmacology ( 12.3 )] . (label Kabozantinib, Interaksi obat)

  • Ketamindepresan SSPModerat

    In addition, ketamine and thiopental anesthesia were significantly prolonged in rats receiving probenecid. (label Probenesid, Interaksi obat)

  • LevetirasetamantikonvulsanModerat

    Renal clearance of ucb L057 in the presence of probenecid decreased 60%, probably related to competitive inhibition of tubular secretion of ucb L057. (label Levetirasetam, Interaksi obat)

  • LevofloksasinfluorokuinolonModerat

    However, these changes do not warrant dosage adjustment for Levofloxacin in 5% Dextrose Injection when probenecid or cimetidine is co-administered. (label Levofloksasin, Interaksi obat)

  • Metazolamidpenghambat karbonat anhidraseModerat

    Probenecid produces an insignificant increase in free sulfonamide plasma concentrations but a significant increase in total sulfonamide plasma levels. (label Probenesid, Interaksi obat)

  • MetotreksatimunosupresanModerat

    Probenecid increases plasma concentrations of methotrexate in both animals and humans. (label Probenesid, Peringatan)

  • Nafsilinantibiotik penisilinModerat

    Drug Interactions When probenecid is used to elevate plasma concentrations of penicillin or other beta-lactams, or when such drugs are given to patients taking probenecid therapeutically, high plasma concentrations of the other drug may increase the incidence of adverse reactions associated with that drug. (label Probenesid, Interaksi obat)

  • NaproksenOAINSModerat

    Probenecid Clinical Impact: Probenecid given concurrently increases naproxen anion plasma levels and extends its plasma half-life significantly. (label Naproksen, Interaksi obat)

  • Probenecid : May inhibit renal excretion of metabolites of PHEBURANE including phenylacetate and phenylacetylglutamine; monitor for potential neurotoxicity. (label Natrium fenilbutirat, Interaksi obat)

  • Oksasilinantibiotik penisilinModerat

    Drug Interactions When probenecid is used to elevate plasma concentrations of penicillin or other beta-lactams, or when such drugs are given to patients taking probenecid therapeutically, high plasma concentrations of the other drug may increase the incidence of adverse reactions associated with that drug. (label Probenesid, Interaksi obat)

  • In patients on probenecid who require a mild analgesic agent the use of acetaminophen rather than small doses of salicylates would be preferred. (label Probenesid, Peringatan)

  • In patients on probenecid who require a mild analgesic agent the use of acetaminophen rather than small doses of salicylates would be preferred. (label Probenesid, Peringatan)

  • In patients on probenecid who require a mild analgesic agent the use of acetaminophen rather than small doses of salicylates would be preferred. (label Probenesid, Peringatan)

  • In patients on probenecid who require a mild analgesic agent the use of acetaminophen rather than small doses of salicylates would be preferred. (label Probenesid, Peringatan)

  • Perak sulfadiazinsulfonamidaModerat

    Probenecid produces an insignificant increase in free sulfonamide plasma concentrations but a significant increase in total sulfonamide plasma levels. (label Probenesid, Interaksi obat)

  • Pioglitazon dan glimepiridtiazolidindionModerat

    Probenecid may prolong or enhance the action of oral sulfonylureas and thereby increase the risk of hypoglycemia. (label Probenesid, Interaksi obat)

  • RifampisinantibiotikModerat

    Concomitant use with probenecid and cotrimoxazole increases the concentration of rifampin which may increase the risk of rifampin toxicities. (label Rifampisin, Interaksi obat)

  • SefadroksilsefalosporinModerat

    Drug Interactions When probenecid is used to elevate plasma concentrations of penicillin or other beta-lactams, or when such drugs are given to patients taking probenecid therapeutically, high plasma concentrations of the other drug may increase the incidence of adverse reactions associated with that drug. (label Probenesid, Interaksi obat)

  • SefaklorsefalosporinModerat

    Drug Interactions When probenecid is used to elevate plasma concentrations of penicillin or other beta-lactams, or when such drugs are given to patients taking probenecid therapeutically, high plasma concentrations of the other drug may increase the incidence of adverse reactions associated with that drug. (label Probenesid, Interaksi obat)

  • SefdinirsefalosporinModerat

    Drug Interactions When probenecid is used to elevate plasma concentrations of penicillin or other beta-lactams, or when such drugs are given to patients taking probenecid therapeutically, high plasma concentrations of the other drug may increase the incidence of adverse reactions associated with that drug. (label Probenesid, Interaksi obat)

  • SefepimsefalosporinModerat

    Drug Interactions When probenecid is used to elevate plasma concentrations of penicillin or other beta-lactams, or when such drugs are given to patients taking probenecid therapeutically, high plasma concentrations of the other drug may increase the incidence of adverse reactions associated with that drug. (label Probenesid, Interaksi obat)

  • SefiksimsefalosporinModerat

    Drug Interactions When probenecid is used to elevate plasma concentrations of penicillin or other beta-lactams, or when such drugs are given to patients taking probenecid therapeutically, high plasma concentrations of the other drug may increase the incidence of adverse reactions associated with that drug. (label Probenesid, Interaksi obat)

  • SefoksitinsefalosporinModerat

    Drug Interactions When probenecid is used to elevate plasma concentrations of penicillin or other beta-lactams, or when such drugs are given to patients taking probenecid therapeutically, high plasma concentrations of the other drug may increase the incidence of adverse reactions associated with that drug. (label Probenesid, Interaksi obat)

  • SefotetansefalosporinModerat

    Drug Interactions When probenecid is used to elevate plasma concentrations of penicillin or other beta-lactams, or when such drugs are given to patients taking probenecid therapeutically, high plasma concentrations of the other drug may increase the incidence of adverse reactions associated with that drug. (label Probenesid, Interaksi obat)

  • SefpodoksimsefalosporinModerat

    Drug Interactions When probenecid is used to elevate plasma concentrations of penicillin or other beta-lactams, or when such drugs are given to patients taking probenecid therapeutically, high plasma concentrations of the other drug may increase the incidence of adverse reactions associated with that drug. (label Probenesid, Interaksi obat)

  • SefprozilsefalosporinModerat

    Drug Interactions When probenecid is used to elevate plasma concentrations of penicillin or other beta-lactams, or when such drugs are given to patients taking probenecid therapeutically, high plasma concentrations of the other drug may increase the incidence of adverse reactions associated with that drug. (label Probenesid, Interaksi obat)

  • SeftarolinsefalosporinModerat

    Drug Interactions When probenecid is used to elevate plasma concentrations of penicillin or other beta-lactams, or when such drugs are given to patients taking probenecid therapeutically, high plasma concentrations of the other drug may increase the incidence of adverse reactions associated with that drug. (label Probenesid, Interaksi obat)

  • SeftazidimsefalosporinModerat

    Drug Interactions When probenecid is used to elevate plasma concentrations of penicillin or other beta-lactams, or when such drugs are given to patients taking probenecid therapeutically, high plasma concentrations of the other drug may increase the incidence of adverse reactions associated with that drug. (label Probenesid, Interaksi obat)

  • SeftriaksonsefalosporinModerat

    Drug Interactions When probenecid is used to elevate plasma concentrations of penicillin or other beta-lactams, or when such drugs are given to patients taking probenecid therapeutically, high plasma concentrations of the other drug may increase the incidence of adverse reactions associated with that drug. (label Probenesid, Interaksi obat)

  • SiprofloksasinfluorokuinolonModerat

    Decrease ciprofloxacin absorption, resulting in lower serum and urine levels Probenecid Use with caution (interferes with renal tubular secretion of ciprofloxacin and increases ciprofloxacin serum levels) Potentiation of ciprofloxacin toxicity may occur. (label Siprofloksasin, Interaksi obat)

  • SulfadiazinsulfonamidaModerat

    Probenecid produces an insignificant increase in free sulfonamide plasma concentrations but a significant increase in total sulfonamide plasma levels. (label Probenesid, Interaksi obat)

  • Probenecid produces an insignificant increase in free sulfonamide plasma concentrations but a significant increase in total sulfonamide plasma levels. (label Probenesid, Interaksi obat)

  • SulindakOAINSModerat

    Probenecid given concomitantly with sulindac had only a slight effect on plasma sulfide levels, while plasma levels of sulindac and sulfone were increased. (label Probenesid, Interaksi obat)

  • Probenecid Clinical Impact: Probenecid given concurrently increases naproxen anion plasma levels and extends its plasma half-life significantly. (label Sumatriptan dan naproksen, Interaksi obat)

  • Torasemiddiuretik loopModerat

    Organic Anion Drugs Coadministration of organic anion drugs (e.g., probenecid) that undergo significant renal tubular secretion have the potential to reduce secretion of torsemide into the proximal tubule and thereby decreases the diuretic activity of torsemide. (label Torasemid, Interaksi obat)

  • In patients on probenecid who require a mild analgesic agent the use of acetaminophen rather than small doses of salicylates would be preferred. (label Probenesid, Peringatan)

  • ValgansiklovirantivirusModerat

    Didanosine ↔ Ganciclovir ↑ Didanosine Patients should be closely monitored for didanosine toxicity (e.g., pancreatitis) Probenecid ↑ Ganciclovir Valganciclovir hydrochloride dose may need to be reduced. (label Valgansiklovir, Interaksi obat)

  • ZonisamidantikonvulsanModerat

    Probenecid produces an insignificant increase in free sulfonamide plasma concentrations but a significant increase in total sulfonamide plasma levels. (label Probenesid, Interaksi obat)

Penyebutan minor (18)

  • Alopurinolpenghambat xantin oksidaseMinor

    Falsely high readings for theophylline have been reported in an in vitro study, using the Schack and Waxler technique, when therapeutic concentrations of theophylline and probenecid were added to human plasma. (label Probenesid, Interaksi obat)

  • AminofilinmetilxantinMinor

    Falsely high readings for theophylline have been reported in an in vitro study, using the Schack and Waxler technique, when therapeutic concentrations of theophylline and probenecid were added to human plasma. (label Probenesid, Interaksi obat)

  • These include probenecid, cholestyramine, and some antibiotics (e.g., erythromycin, rifampicin, ampicillin, and chloramphenicol). (label Entakapon, Perhatian)

  • Ergotamin dan kafeinalkaloid ergotMinor

    Falsely high readings for theophylline have been reported in an in vitro study, using the Schack and Waxler technique, when therapeutic concentrations of theophylline and probenecid were added to human plasma. (label Probenesid, Interaksi obat)

  • Febuksostatpenghambat xantin oksidaseMinor

    Falsely high readings for theophylline have been reported in an in vitro study, using the Schack and Waxler technique, when therapeutic concentrations of theophylline and probenecid were added to human plasma. (label Probenesid, Interaksi obat)

  • GabapentinantikonvulsanMinor

    Probenecid Probenecid is a blocker of renal tubular secretion. (label Gabapentin, Interaksi obat)

  • Probenecid : May affect renal excretion of metabolites of glycerol phenylbutyrate, including phenylacetylglutamine (PAGN) and PAA. (label Gliserol fenilbutirat, Interaksi obat)

  • These include probenecid, cholestyramine, and some antibiotics (e.g., erythromycin, rifampicin, ampicillin and chloramphenicol). (label Karbidopa, levodopa, dan entakapon, Interaksi obat)

  • WARNINGS Exacerbation of gout following therapy with probenecid may occur; in such cases colchicine or other appropriate therapy is advisable. (label Probenesid, Peringatan)

  • LorazepambenzodiazepinMinor

    These include agents such as indomethacin, acetaminophen, naproxen, ketoprofen, meclofenamate, lorazepam, and rifampin. (label Probenesid, Interaksi obat)

  • These include agents such as indomethacin, acetaminophen, naproxen, ketoprofen, meclofenamate, lorazepam, and rifampin. (label Probenesid, Interaksi obat)

  • Probenecid is known to inhibit the renal transport of many organic compounds, including aminohippuric acid, and may affect renal excretion of phenylacetylglutamine and hippurate. (label Natrium fenilasetat dan natrium benzoat, Interaksi obat)

  • NitrofurantoinantibiotikMinor

    Uricosuric Drugs Uricosuric drugs, such as probenecid and sulfinpyrazone, can inhibit renal tubular secretion of nitrofurantoin. (label Nitrofurantoin, Interaksi obat)

  • OfloksasinfluorokuinolonMinor

    Probenecid The concomitant use of probenecid with certain other quinolones has been reported to affect renal tubular secretion. (label Ofloksasin, Interaksi obat)

  • PentoksifilinmetilxantinMinor

    Falsely high readings for theophylline have been reported in an in vitro study, using the Schack and Waxler technique, when therapeutic concentrations of theophylline and probenecid were added to human plasma. (label Probenesid, Interaksi obat)

  • PirazinamidantibiotikMinor

    The uricosuric action of probenecid is also antagonized by pyrazinamide. (label Probenesid, Interaksi obat)

  • Prazosinpenyekat alfaMinor

    …hypoglycemics–insulin, chlorpropamide, phenformin, tolazamide, and tolbutamide; (3) tranquilizers and sedatives–chlordiazepoxide, diazepam, and phenobarbital; (4) antigout–allopurinol, colchicine, and probenecid; (5) antiarrhythmics–procainamide, propranolol (see WARNINGS however), and quinidine; and (6) analgesics, antipyretics and anti-inflammatories–propoxyphene, aspirin, indomethacin,… (label Prazosin, Interaksi obat)

  • TeofilinmetilxantinMinor

    Falsely high readings for theophylline have been reported in an in vitro study, using the Schack and Waxler technique, when therapeutic concentrations of theophylline and probenecid were added to human plasma. (label Probenesid, Interaksi obat)

Tidak ada interaksi bermakna yang dilaporkan (2)

  • GentamisinaminoglikosidaTanpa interaksi

    Probenecid does not affect renal tubular transport of gentamicin. (label Gentamisin, Interaksi obat)

  • MikofenolatimunosupresanTanpa interaksi

    Examples Acyclovir, ganciclovir, probenecid, valacyclovir, valganciclovir Combination Oral Contraceptives Clinical Impact Concomitant use with mycophenolate mofetil decreased the systemic exposure to levonorgestrel, but did not affect the systemic exposure to ethinylestradiol [see Clinical Pharmacology ( 12.3 )], which may result in reduced combination oral contraceptive… (label Mikofenolat, Interaksi obat)

Periksa Probenesid terhadap semua yang Anda gunakan. Tambahkan seluruh daftar Anda; setiap pasangan diperiksa sekaligus.

Buka di pemeriksa

Bukan nasihat medis. Tingkat keparahan mencerminkan kata-kata dalam label, bukan keadaan Anda. Tanda “mayor” bisa merupakan hal yang rutin di bawah pengawasan, dan tanda “minor” bisa menjadi penting pada dosis tinggi. Tanyakan kepada apoteker.